Clementia pharmaceuticals IPO 

Clementia pharmaceuticals IPO

The Clementia Pharmaceuticals IPO planned for the middle months of 2017 seemed, on the face of it, to be a bright prospect for all concerned. The Montreal based manufacturer of treatments for rare bone and tissue complaints, was looking to sell 7.15 million shares of common stock for a price of $14 a share and […]